Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $544.17 million. The enterprise value is $211.61 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 53.09 million shares outstanding. The number of shares has increased by 33.98% in one year.
| Current Share Class | 53.09M |
| Shares Outstanding | 53.09M |
| Shares Change (YoY) | +33.98% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 4.16% |
| Owned by Institutions (%) | 37.37% |
| Float | 21.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 23.81 |
| Quick Ratio | 23.53 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.60% and return on invested capital (ROIC) is -23.25%.
| Return on Equity (ROE) | -31.60% |
| Return on Assets (ROA) | -22.09% |
| Return on Invested Capital (ROIC) | -23.25% |
| Return on Capital Employed (ROCE) | -29.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.44M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.84% in the last 52 weeks. The beta is 1.19, so TYRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -36.84% |
| 50-Day Moving Average | 10.17 |
| 200-Day Moving Average | 16.53 |
| Relative Strength Index (RSI) | 59.68 |
| Average Volume (20 Days) | 334,227 |
Short Selling Information
The latest short interest is 3.94 million, so 7.41% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short Previous Month | 3.75M |
| Short % of Shares Out | 7.41% |
| Short % of Float | 18.67% |
| Short Ratio (days to cover) | 11.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -104.18M |
| Pretax Income | -80.88M |
| Net Income | -86.48M |
| EBITDA | -103.66M |
| EBIT | -104.18M |
| Earnings Per Share (EPS) | -$1.51 |
Full Income StatementBalance Sheet
The company has $341.44 million in cash and $6.22 million in debt, giving a net cash position of $335.22 million or $6.31 per share.
| Cash & Cash Equivalents | 341.44M |
| Total Debt | 6.22M |
| Net Cash | 335.22M |
| Net Cash Per Share | $6.31 |
| Equity (Book Value) | 343.15M |
| Book Value Per Share | 6.76 |
| Working Capital | 332.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.77 million and capital expenditures -$664,000, giving a free cash flow of -$70.44 million.
| Operating Cash Flow | -69.77M |
| Capital Expenditures | -664,000 |
| Free Cash Flow | -70.44M |
| FCF Per Share | -$1.33 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |